G1 Therapeutics, Inc.
GTHX · NASDAQ
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$47,967 | -$147,559 | -$148,352 | -$99,254 |
| Dep. & Amort. | $513 | $530 | $469 | $582 |
| Deferred Tax | $1,228 | $0 | $590 | -$545 |
| Stock-Based Comp. | $14,510 | $20,589 | $22,319 | $18,770 |
| Change in WC | -$5,203 | -$5,307 | -$8,838 | -$4,076 |
| Other Non-Cash | -$1,418 | $3,127 | $1,704 | $781 |
| Operating Cash Flow | -$38,337 | -$128,620 | -$132,108 | -$83,742 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | -$506 | $0 | $0 |
| Net Acquisitions | $0 | $50,023 | $0 | $152 |
| Inv. Purchases | -$124,690 | -$65,023 | $0 | $0 |
| Inv. Sales/Matur. | $127,500 | $15,000 | $0 | $0 |
| Other Inv. Act. | $2,810 | -$50,023 | $0 | $152 |
| Investing Cash Flow | $2,810 | -$50,529 | $0 | $152 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$26,688 | $0 | $55,000 | $20,000 |
| Stock Issued | -$224 | $52,383 | $86,429 | $2,308 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$224 | $112 | $4,434 | $1,688 |
| Financing Cash Flow | -$26,912 | $52,495 | $145,863 | $21,688 |
| Forex Effect | $63 | $0 | $0 | $0 |
| Net Chg. in Cash | -$62,376 | -$126,654 | $13,755 | -$61,902 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $94,657 | $221,561 | $207,806 | $269,708 |
| End Cash | $32,281 | $94,907 | $221,561 | $207,806 |
| Free Cash Flow | -$38,337 | -$129,126 | -$132,108 | -$83,742 |